In this bonus episode of Phacilitate Talks, recorded LIVE at Advanced Therapies Connect (September 2021), Georgi Makin speaks to Amritha Jaishankar, Executive Director at Maryland Stem Cell Research Fund.  This investment and funding Spotlight episode focuses on the past year of high investment, Women in Advanced Therapies and what to expect from Amritha at Advanced Therapies Connect later today.  It's not too late to join us! Register and join the conversation via:...

In this bonus episode of Phacilitate Talks, recorded LIVE at Advanced Therapies Connect (September 2021), Georgi Makin speaks to Miguel Forte, CEO at Bone Therapeutics and Magali Taiel, CMO at GenSight Biologics.  This European Spotlight episode focuses on unique challenges in the industry in Europe, as well as what each speaker will be discussing at the event.  It's not too late to join us! Register and join the conversation via: https://bit.ly/3zLP3qH QUICK LINKS:  Georgi Makin:...

The third episode of season 2 of Phacilitate Talks allows us to finally visit a financial theme as we pitch private equity against strategics…  Watch the full episode via the Phacilitate website: https://bit.ly/3nTtxy1   Welcome to the third episode of season 2 of Phacilitate Talks! This week, we are finally able to re-visit our schedule as we discuss the financial landscape advanced therapies, pitching private equity against strategics.   As we continue our journey on the road to...

For the second episode of season 2 of Phacilitate Talks, we interrupt planned transmission to discuss the future of AAV with Nicole Paulk, following the recent FDA AdComm. Welcome to the second episode of season 2 of Phacilitate Talks! This week, we interrupt planned transmission to discuss the future of AAV following the FDA AdComm in early September. Watch the full episode via the Phacilitate website: https://bit.ly/3hrQVP3 As we continue our journey on the road to Miami, Phacilitate...

Season 2 of Phacilitate Talks kicks off with a bang as Bruce Levine and Audrey Greenberg explore key questions associated with building capacity, acquiring talent and looking ahead in a post-pandemic world.   Welcome to season 2 of Phacilitate Talks! This season, we have left the pandemic norm and returned to offices, in-person meetings and even live events!   Watch the full video via the Phacilitate website: https://bit.ly/3kn7Naf   As we begin our journey on the road to Miami,...

Welcome to the first episode of Phacilitate Talks! Lindsey Clarke the European Head of Cell and Gene Therapy at bio-techne, Anthony Davies, CEO of Dark Horse Consulting and Cenk Sumen CTO of Stemson Therapeutics dig into how their teams have adjusted to remote work, how covid-19 has impacted clinical trials and what we do as global community to better prepare for the next pandemic.   In this episode I refer to a webinar with Kings College, Sexton Biotechnologies and BioBridge Global...

Part 2 of Anthony and Michael's meet up to Nina Bauer and Lance Holland.*Opinions expressed are solely the interviewee's own and do not express the views or opinions of their respective employers.* The bulk of the chat was around Mesoblast's pending FDA decision for Ryoncil, their pediatric graft versus host disease therapy. The panel took it to a vote on will it be approved or rejected. Listen and find out how the panel judged it and of course, you can see the widely reported outcome in...

The fourth in our series of Women in Advanced Therapies interviews, where we'll be talking to a selection of the women featured in the '11 Most Influential Women in Advanced Therapies' eBook.  Link to the eBook - https://bit.ly/2HOGR3Q In this episode we're delighted to be interviewing Emily Whitehead, cancer survivor and ambassador for CAR-T therapy. At only six-years-old, Emily Whitehead was facing a life-threatening recurrence of acute lymphoblastic leukemia, the most common childhood...

In this episode, Anthony and Michael talk to Nina Bauer, the Head of Commercial, Gene Editing and Novel Modalities at MilliporeSigma and Lance Holland, Associate Director, External Vector Manufacturing at bluebird bio.  The discussion starts with a look at the challenges brought by Covid-19 with regards to finding a new way of working with your CDMO, in particular conducting audits. Anthony's solution? Use GoPros!  Nina puts a question to the group around recruiting diverse talent. With a...

In this episode, Anthony and I have a great chat with David Smith, President and Chief Commercial Officer of Akron Biotech and Oliver Ball, Business Development Manager at Stemmatters.Oliver graduated with distinction from Kings College London in 2016 with a Masters in 'Cellular Therapy From Bench to Market'.David Smith has over 20 years of experience in cell therapy and has been involved in commercialising several therapeutic products all over the globe.It's a great conversation with two...

Our third in the fantastic Women in Advanced Therapies interviews!  The series highlights a selection of the women featured in the '11 Most Influential Women in Advanced Therapies' report published by Phacilitate earlier this year.  In this episode, Nicola Ambler sits down with biotech CEO Maria Fardis of Iovance, a leader in the race for curing solid tumors with TIL therapy. Maria shares her mentors, the conflicts women must wrestle with when pursuing careers and her ethos when building...

This is the second episode in our series of Women in Advanced Therapies interviews! The series highlights a selection of the women featured in the '11 Most Influential Women in Advanced Therapies' report published by Phacilitate earlier this year. Jeanne Loring, the Director of Regenerative Medicine at the Scripps Research Institute and Co-Founder of Aspen Neuroscience shares her struggles as a young post-doc rising through academia and then transitioning into industry when launching her...

In this episode, hosts Anthony Davies and Michael Adeniya get to talk to two cell therapy CMC experts in Delfi Krishna, Director Cell and Gene Therapy Platform: R&D Strategy at GSK and Jacob Peterson, Corporate Vice President Head of Stem Cell R&D with Novo Nordisk.  The discussion tackled cellular analytics, manufacturing and the impact the Covid-19 pandemic is having on both capacity and clinical pipelines.  Delfi kicks us off with her company's challenge around managing the cost of...

This episode is the first in our series of Women in Advanced Therapies interviews, where we'll be talking to a selection of the women featured in the '11 Most Influential Women in Advanced Therapies' report published by Phacilitate earlier this year. Claudia Zylberberg, Founder and CEO of Akron Biotech shares her journey through the cell therapy industry, her passion for sustainability and drops some wisdom for the class of 2020.  Thanks to Jennifer Manning for an excellent interview!  Link...

Welcome to Phacilitate Talks, a socially distanced show for the advanced therapies community, getting you close to cell therapy experts and asking them the big questions.